TVGN Tevogen Bio Holdings Inc.
Healthcare$8.60-10.51%ClosedMarket Cap: $36.0M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
-3.05
P/S
0.00
EV/EBITDA
-1.86
DCF Value
$-1.68
FCF Yield
-32.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
241.4%
ROA
-433.9%
ROIC
5744.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-5.4M | $-5.4M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-4.6M | $-4.7M | $— | — |
| FY null | $0.00 | NaN% | $-26.1M | $-26.3M | $— | — |
| Q3 null | $0.00 | NaN% | $-5.7M | $-5.7M | $— | — |
| Q2 null | $0.00 | NaN% | $-5.4M | $-5.5M | $— | — |
| Q1 null | $0.00 | NaN% | $-10.4M | $-10.4M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-9.4M | $-9.2M | $— | — |
| FY null | $0.00 | -Infinity% | $-53.6M | $-10.1M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-6.1M | $-5.9M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-8.6M | $-6.1M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-29.5M | $11.3M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-2.0M | $-3.6M | $-0.26 | — |